FDA Head Von Eschenbach Resigning In January; Industry Awaits Successor
This article was originally published in The Rose Sheet
Executive Summary
FDA Commissioner Andrew von Eschenbach will return to Texas upon resigning his post Jan. 20, closing out a bumpy tenure marked by some notable successes